ECTRIMS 2019: Impact of age on treatment decisions

Per Solberg | ECTRIMS 2019 | SYYSKUU 12, 2019

Asiantuntija: Per Solberg

Higher age is associated with quantitative and functional changes in the innate and adaptive immune system, and an age dependent reduction in efficacy of disease modifying therapies. In this MEDtalk Per Solberg Sørensen present data that shows, that the choice of initial disease modifying therapies differs according to the age of the patient. Fewer patients above 40 years started with a highly effective disease modifying therapies.